View Clinical Trial (Medical Research Study)

Flibanserin for the Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women - NCT00996372-(Clinical Trial 369606)



ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.


Signup
City:  Tacoma
State:  
WA
Zip Code:
Conditions: Sexual Dysfunctions, Psychological
Purpose: The objective of this trial is to assess the safety and efficacy of 24-week course of flibanserin for the treatment of Hypoactive Sexual Desire Disorder (HSDD) in naturally postmenopausal women.
Study summary:
Criteria: Inclusion Criteria: - Naturally postmenopausal women of any age with at least one ovary - Diagnosis of Hypoactive Sexual Desire Disorder, generalized acquired type,of at least six months duration - Stable, monogamous heterosexual relationship for at least one year - Willing to discuss sexual issues - Willing to engage in sexual activity at least once a month - Normal Pap smear - Normal mammogram - Normal uterine lining - Able to comply with daily use of handheld data entry device Exclusion Criteria: - Sexual dysfunctions other than HSDD, such as Sexual Aversion Disorder, Substance-induced Sexual Dysfunction, Dyspareunia, Vaginismus, Gender Identity Disorder, Paraphilia and Sexual Dysfunction due to a General Medical Condition - Partner with inadequately treated organic or psychosexual dysfunction - Sexual function impaired by psychiatric disorder - Sexual function impaired by gynecological disorder - Major Depression - Suicidal behavior or ideation - Major life stress that could impair sexual function - Substance abuse
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
Trials Alerts: If you would like to be notified of new clinical trials as they become available please register for a free account.
Data Source: ClinicalTrials.gov
Date Processed: August 16, 2010
Modifications to
this listing:		 Only selected fields are shown, please use the link above to view all information about this clinical trial.